Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Catalyst Biosciences, Inc. (CBIO : NSDQ)
 
 • Company Description   
Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.

Number of Employees: 45

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.38 Daily Weekly Monthly
20 Day Moving Average: 178,888 shares
Shares Outstanding: 31.48 (millions)
Market Capitalization: $11.96 (millions)
Beta: 2.02
52 Week High: $5.20
52 Week Low: $0.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -34.48% -28.26%
12 Week -36.53% -28.67%
Year To Date -58.42% -49.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
611 GATEWAY BLVD. SUITE 710
-
SOUTH SAN FRANCISCO,CA 94080
USA
ph: 650-871-0761
fax: 336-480-2107
investors@catbio.com http://www.catalystbiosciences.com
 
 • General Corporate Information   
Officers
Nassim Usman - President and Chief Executive Officer
Augustine Lawlor - Chairman
Seline Miller - Interim Chief Financial Officer
Errol B. De Souza - Director
Andrea Hunt - Director

Peer Information
Catalyst Biosciences, Inc. (CORR.)
Catalyst Biosciences, Inc. (RSPI)
Catalyst Biosciences, Inc. (CGXP)
Catalyst Biosciences, Inc. (BGEN)
Catalyst Biosciences, Inc. (GTBP)
Catalyst Biosciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 14888D208
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 31.48
Most Recent Split Date: 2.00 (0.07:1)
Beta: 2.02
Market Capitalization: $11.96 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.44 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.67 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.44
Price/Cash Flow: -
Price / Sales: 1.79
EPS Growth
vs. Year Ago Period: 41.77%
vs. Previous Quarter: 28.12%
Sales Growth
vs. Year Ago Period: -45.88%
vs. Previous Quarter: -67.46%
ROE
03/31/22 - -149.54
12/31/21 - -120.84
09/30/21 - -106.12
ROA
03/31/22 - -115.88
12/31/21 - -99.06
09/30/21 - -87.77
Current Ratio
03/31/22 - 2.78
12/31/21 - 3.63
09/30/21 - 4.29
Quick Ratio
03/31/22 - 2.78
12/31/21 - 3.63
09/30/21 - 4.29
Operating Margin
03/31/22 - -1,200.77
12/31/21 - -1,198.32
09/30/21 - -1,248.43
Net Margin
03/31/22 - -1,200.77
12/31/21 - -1,198.32
09/30/21 - -1,248.43
Pre-Tax Margin
03/31/22 - -1,200.77
12/31/21 - -1,198.32
09/30/21 - -1,248.54
Book Value
03/31/22 - 0.86
12/31/21 - 1.31
09/30/21 - 1.94
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©